1 Market Overview of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing 1.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview 1.1.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Scope 1.1.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Status and Outlook 1.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2027) 1.4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Region (2016-2021) 1.5 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 1.6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 1.6.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 1.6.3 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 1.6.4 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 1.6.5 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) 2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview by Type 2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Type (2016-2021) 2.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2022-2027) 2.4 AAV 2.5 Adenoviral 2.6 Lentiviral 2.7 Retroviral 2.8 Plasmid DNA 2.9 Other Vectors 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview by Application 3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Application (2016-2021) 3.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2022-2027) 3.4 Cancers 3.5 Inherited Disorders 3.6 Viral Infections 3.7 Others 4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Competition Analysis by Players 4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2020) 4.3 Date of Key Players Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market 4.4 Global Top Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Headquarters and Area Served 4.5 Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service 4.6 Competitive Status 4.6.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 BioReliance 5.1.1 BioReliance Profile 5.1.2 BioReliance Main Business 5.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.1.4 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.1.5 BioReliance Recent Developments 5.2 Cobra Biologics 5.2.1 Cobra Biologics Profile 5.2.2 Cobra Biologics Main Business 5.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.2.4 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.2.5 Cobra Biologics Recent Developments 5.3 Oxford BioMedica 5.5.1 Oxford BioMedica Profile 5.3.2 Oxford BioMedica Main Business 5.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.3.4 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.3.5 UniQure Recent Developments 5.4 UniQure 5.4.1 UniQure Profile 5.4.2 UniQure Main Business 5.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.4.4 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.4.5 UniQure Recent Developments 5.5 FinVector 5.5.1 FinVector Profile 5.5.2 FinVector Main Business 5.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.5.4 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.5.5 FinVector Recent Developments 5.6 MolMed 5.6.1 MolMed Profile 5.6.2 MolMed Main Business 5.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.6.4 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.6.5 MolMed Recent Developments 5.7 MassBiologics 5.7.1 MassBiologics Profile 5.7.2 MassBiologics Main Business 5.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.7.4 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.7.5 MassBiologics Recent Developments 5.8 Richter-Helm 5.8.1 Richter-Helm Profile 5.8.2 Richter-Helm Main Business 5.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.8.4 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.8.5 Richter-Helm Recent Developments 5.9 FUJIFILM Diosynth Biotechnologies 5.9.1 FUJIFILM Diosynth Biotechnologies Profile 5.9.2 FUJIFILM Diosynth Biotechnologies Main Business 5.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments 5.10 Lonza 5.10.1 Lonza Profile 5.10.2 Lonza Main Business 5.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.10.4 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.10.5 Lonza Recent Developments 5.11 Aldevron 5.11.1 Aldevron Profile 5.11.2 Aldevron Main Business 5.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.11.4 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.11.5 Aldevron Recent Developments 5.12 Eurogentec 5.12.1 Eurogentec Profile 5.12.2 Eurogentec Main Business 5.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.12.4 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.12.5 Eurogentec Recent Developments 5.13 Cell and Gene Therapy Catapult 5.13.1 Cell and Gene Therapy Catapult Profile 5.13.2 Cell and Gene Therapy Catapult Main Business 5.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.13.4 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.13.5 Cell and Gene Therapy Catapult Recent Developments 5.14 Biovian 5.14.1 Biovian Profile 5.14.2 Biovian Main Business 5.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.14.4 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.14.5 Biovian Recent Developments 5.15 Thermo Fisher Scientific (Brammer Bio) 5.15.1 Thermo Fisher Scientific (Brammer Bio) Profile 5.15.2 Thermo Fisher Scientific (Brammer Bio) Main Business 5.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments 5.16 VGXI 5.16.1 VGXI Profile 5.16.2 VGXI Main Business 5.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.16.4 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.16.5 VGXI Recent Developments 5.17 PlasmidFactory 5.17.1 PlasmidFactory Profile 5.17.2 PlasmidFactory Main Business 5.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.17.4 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.17.5 PlasmidFactory Recent Developments 5.18 bluebird bio 5.18.1 bluebird bio Profile 5.18.2 bluebird bio Main Business 5.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.18.4 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.18.5 bluebird bio Recent Developments 5.19 Novasep 5.19.1 Novasep Profile 5.19.2 Novasep Main Business 5.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.19.4 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.19.5 Novasep Recent Developments 5.20 Spark Therapeutics 5.20.1 Spark Therapeutics Profile 5.20.2 Spark Therapeutics Main Business 5.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.20.4 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.20.5 Spark Therapeutics Recent Developments 5.21 Vigene Biosciences 5.21.1 Vigene Biosciences Profile 5.21.2 Vigene Biosciences Main Business 5.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions 5.21.4 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) & (2016-2021) 5.21.5 Vigene Biosciences Recent Developments 6 North America 6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Dynamics 11.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industry Trends 11.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers 11.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges 11.4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Region (2016-2021) Table 4. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size Share by Region (2022-2027) Table 6. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2016-2021) Table 9. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2022-2027) Table 11. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2016-2021) Table 14. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2022-2027) Table 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$ Million) by Players (2016-2021) Table 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2020) Table 19. Date of Key Manufacturers Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Table 20. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Top Players Headquarters and Area Served Table 21. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service Table 22. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. BioReliance Basic Information List Table 25. BioReliance Description and Business Overview Table 26. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 27. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of BioReliance (2016-2021) Table 28. BioReliance Recent Developments Table 29. Cobra Biologics Basic Information List Table 30. Cobra Biologics Description and Business Overview Table 31. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 32. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Cobra Biologics (2016-2021) Table 33. Cobra Biologics Recent Developments Table 34. Oxford BioMedica Basic Information List Table 35. Oxford BioMedica Description and Business Overview Table 36. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 37. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Oxford BioMedica (2016-2021) Table 38. Oxford BioMedica Recent Developments Table 39. UniQure Basic Information List Table 40. UniQure Description and Business Overview Table 41. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 42. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of UniQure (2016-2021) Table 43. UniQure Recent Developments Table 44. FinVector Basic Information List Table 45. FinVector Description and Business Overview Table 46. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 47. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of FinVector (2016-2021) Table 48. FinVector Recent Developments Table 49. MolMed Basic Information List Table 50. MolMed Description and Business Overview Table 51. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 52. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of MolMed (2016-2021) Table 53. MolMed Recent Developments Table 54. MassBiologics Basic Information List Table 55. MassBiologics Description and Business Overview Table 56. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 57. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of MassBiologics (2016-2021) Table 58. MassBiologics Recent Developments Table 59. Richter-Helm Basic Information List Table 60. Richter-Helm Description and Business Overview Table 61. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 62. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Richter-Helm (2016-2021) Table 63. Richter-Helm Recent Developments Table 64. FUJIFILM Diosynth Biotechnologies Basic Information List Table 65. FUJIFILM Diosynth Biotechnologies Description and Business Overview Table 66. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 67. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of FUJIFILM Diosynth Biotechnologies (2016-2021) Table 68. FUJIFILM Diosynth Biotechnologies Recent Developments Table 69. Lonza Basic Information List Table 70. Lonza Description and Business Overview Table 71. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 72. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Lonza (2016-2021) Table 73. Lonza Recent Developments Table 74. Aldevron Basic Information List Table 75. Aldevron Description and Business Overview Table 76. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 77. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Aldevron (2016-2021) Table 78. Aldevron Recent Developments Table 79. Eurogentec Basic Information List Table 80. Eurogentec Description and Business Overview Table 81. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 82. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Eurogentec (2016-2021) Table 83. Eurogentec Recent Developments Table 84. Cell and Gene Therapy Catapult Basic Information List Table 85. Cell and Gene Therapy Catapult Description and Business Overview Table 86. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 87. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Cell and Gene Therapy Catapult (2016-2021) Table 88. Cell and Gene Therapy Catapult Recent Developments Table 89. Biovian Basic Information List Table 90. Biovian Description and Business Overview Table 91. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 92. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Biovian (2016-2021) Table 93. Biovian Recent Developments Table 94. Thermo Fisher Scientific (Brammer Bio) Basic Information List Table 95. Thermo Fisher Scientific (Brammer Bio) Description and Business Overview Table 96. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 97. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Thermo Fisher Scientific (Brammer Bio) (2016-2021) Table 98. Thermo Fisher Scientific (Brammer Bio) Recent Developments Table 99. VGXI Basic Information List Table 100. VGXI Description and Business Overview Table 101. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 102. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of VGXI (2016-2021) Table 103. VGXI Recent Developments Table 104. PlasmidFactory Basic Information List Table 105. PlasmidFactory Description and Business Overview Table 106. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 107. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of PlasmidFactory (2016-2021) Table 108. PlasmidFactory Recent Developments Table 109. bluebird bio Basic Information List Table 110. bluebird bio Description and Business Overview Table 111. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 112. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of bluebird bio (2016-2021) Table 113. bluebird bio Recent Developments Table 114. Novasep Basic Information List Table 115. Novasep Description and Business Overview Table 116. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 117. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Novasep (2016-2021) Table 118. Novasep Recent Developments Table 119. Spark Therapeutics Basic Information List Table 120. Spark Therapeutics Description and Business Overview Table 121. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 122. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Spark Therapeutics (2016-2021) Table 123. Spark Therapeutics Recent Developments Table 124. Vigene Biosciences Basic Information List Table 125. Vigene Biosciences Description and Business Overview Table 126. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products, Services and Solutions Table 127. Revenue (US$ Million) in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business of Vigene Biosciences (2016-2021) Table 128. Vigene Biosciences Recent Developments Table 129. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million) Table 130. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million) Table 131. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million) Table 132. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million) Table 133. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2021) & (US$ Million) Table 134. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2022-2027) & (US$ Million) Table 135. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2016-2021) Table 136. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2022-2027) Table 137. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million) Table 138. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million) Table 139. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Players (2016-2021) & (US$ Million) Table 140. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million) Table 141. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends Table 142. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers Table 143. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges Table 144. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions: 2021 VS 2027 Figure 4. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Type in 2021 & 2027 Figure 11. AAV Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Adenoviral Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Lentiviral Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Retroviral Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Plasmid DNA Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Other Vectors Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Application in 2021 & 2027 Figure 18. Cancers Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Inherited Disorders Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Viral Infections Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share in 2020 Figure 24. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027) Figure 25. United States Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 26. Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 27. Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 28. France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 29. U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 30. Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 31. Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 32. Nordic Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2016-2027) Figure 35. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 36. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 37. South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 39. India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 40. Australia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 42. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027) Figure 43. Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 44. Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027) Figure 47. Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 49. UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics Richter-Helm FUJIFILM Diosynth Biotechnologies Lonza Aldevron Eurogentec Cell and Gene Therapy Catapult Biovian Thermo Fisher Scientific (Brammer Bio) VGXI PlasmidFactory bluebird bio Novasep Spark Therapeutics Vigene Biosciences